Publications
2024
O84 Exploring the potential short chain fatty acid-serotonin axis in irritable bowel: insights from an integrated faecal and urinary metabolomic analysis
Conley, T., Slater, R., Burke, A., Gotts, N., Wilson, B., Pritchard, D. M., . . . Probert, C. (2024). O84 Exploring the potential short chain fatty acid-serotonin axis in irritable bowel: insights from an integrated faecal and urinary metabolomic analysis. In Late Breaking Abstracts (pp. A295.2-A296). BMJ Publishing Group Ltd and British Society of Gastroenterology. doi:10.1136/gutjnl-2024-bsg.483
2023
Metabolomics of blood plasma from critically ill patients with suspected ventilator-associated pneumonia
Ahmed, W., Burke, A., Gotts, N., Van Oort, P., Bannard-Smith, J., Morton, B., . . . Fowler, S. (2023). Metabolomics of blood plasma from critically ill patients with suspected ventilator-associated pneumonia. In Molecular pathology and functional genomics (pp. PA2962). European Respiratory Society. doi:10.1183/13993003.congress-2023.pa2962
Quantifying PG : VG ratio and nicotine content in commercially available e-liquids using handheld Raman spectroscopy
Richardson, P. I. C., Burke, A., Gotts, N., & Goodacre, R. (2023). Quantifying PG : VG ratio and nicotine content in commercially available e-liquids using handheld Raman spectroscopy. ANALYST, 148(17), 4002-4011. doi:10.1039/d3an00888f
2022
Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
Roberts, I., Muelas, M. W., Taylor, J. M., Davison, A. S., Xu, Y., Grixti, J. M., . . . Kell, D. B. (2022). Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome. METABOLOMICS, 18(1). doi:10.1007/s11306-021-01859-3
2020
Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
Roberts, I., Muelas, M. W., Taylor, J., Davison, A., Xu, Y., Grixti, J., . . . Kell, D. (2020). Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome. doi:10.1101/2020.12.09.20246389